Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Return on Investment 2010-2023 | BMY

Current and historical return on investment (ROI) values for Bristol Myers Squibb (BMY) over the last 10 years.
  
Bristol Myers Squibb ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2023-06-30 $8.70B $66.69B 12.91%
2023-03-31 $8.80B $66.96B 12.91%
2022-12-31 $7.71B $66.17B 11.23%
2022-09-30 $7.71B $69.70B 10.86%
2022-06-30 $7.66B $69.77B 10.51%
2022-03-31 $7.26B $69.10B 9.64%
2021-12-31 $8.10B $75.61B 10.31%
2021-09-30 $-4.21B $76.96B -5.19%
2021-06-30 $-4.11B $79.38B -4.85%
2021-03-31 $-4.04B $82.18B -4.60%
2020-12-31 $-6.87B $86.22B -7.60%
2020-09-30 $3.45B $91.59B 3.73%
2020-06-30 $2.54B $91.01B 3.17%
2020-03-31 $2.69B $92.82B 3.98%
2019-12-31 $4.98B $95.09B 10.01%
2019-09-30 $6.61B $42.14B 21.41%
2019-06-30 $7.43B $40.58B 29.49%
2019-03-31 $6.17B $20.95B 31.53%
2018-12-31 $5.97B $19.77B 31.42%
2018-09-30 $5.16B $19.44B 27.51%
2018-06-30 $4.18B $18.09B 21.56%
2018-03-31 $4.96B $18.68B 24.43%
2017-12-31 $5.13B $18.82B 24.37%
2017-09-30 $5.52B $21.90B 25.24%
2017-06-30 $5.90B $21.73B 27.05%
2017-03-31 $6.22B $21.77B 28.54%
2016-12-31 $5.92B $22.06B 27.36%
2016-09-30 $4.42B $21.62B 20.70%
2016-06-30 $3.85B $21.66B 17.96%
2016-03-31 $2.28B $21.14B 10.63%
2015-12-31 $2.08B $20.97B 9.48%
2015-09-30 $2.43B $21.91B 10.93%
2015-06-30 $2.45B $21.91B 10.95%
2015-03-31 $2.84B $22.82B 12.60%
2014-12-31 $2.38B $22.23B 10.54%
2014-09-30 $3.31B $22.47B 14.50%
2014-06-30 $3.12B $22.75B 13.85%
2014-03-31 $3.20B $22.90B 14.53%
2013-12-31 $2.89B $23.22B 13.53%
2013-09-30 $2.54B $21.25B 12.29%
2013-06-30 $2.29B $20.82B 11.20%
2013-03-31 $2.82B $20.22B 13.75%
2012-12-31 $4.17B $20.21B 20.04%
2012-09-30 $5.37B $20.51B 25.50%
2012-06-30 $6.57B $21.02B 30.68%
2012-03-31 $7.28B $21.52B 33.81%
2011-12-31 $6.98B $21.24B 32.56%
2011-09-30 $6.86B $21.87B 32.08%
2011-06-30 $6.67B $21.48B 31.04%
2011-03-31 $6.43B $21.18B 29.82%
2010-12-31 $6.07B $20.97B 28.09%
2010-09-30 $5.73B $22.34B 26.53%
2010-06-30 $5.63B $21.82B 26.56%
2010-03-31 $5.51B $21.31B 26.55%
2009-12-31 $5.32B $20.92B 26.15%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $122.484B $46.159B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $141.380B 14.87
Gilead Sciences (GILD) United States $94.411B 12.06
Vertex Pharmaceuticals (VRTX) United States $92.465B 27.24
Regeneron Pharmaceuticals (REGN) United States $90.838B 21.92
CSL (CSLLY) Australia $82.469B 0.00
GSK (GSK) United Kingdom $76.741B 10.41
Moderna (MRNA) United States $40.625B 39.39
Seagen (SGEN) United States $39.099B 0.00
Biogen (BIIB) United States $37.172B 15.81
Argenex SE (ARGX) Netherlands $30.705B 0.00
BioNTech SE (BNTX) Germany $26.613B 6.19
Horizon Therapeutics Public (HZNP) Ireland $26.447B 25.72
Genmab (GMAB) Denmark $24.679B 37.36
Illumina (ILMN) United States $22.235B 159.61
Alnylam Pharmaceuticals (ALNY) United States $21.958B 0.00
BeiGene (BGNE) Cayman Islands $20.227B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.714B 88.82
Exact Sciences (EXAS) United States $13.664B 0.00
Incyte (INCY) United States $13.575B 33.10
Bio-Techne Corp (TECH) United States $11.176B 39.85
Verona Pharma American Depositary Share (VRNA) United Kingdom $10.956B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.868B 30.51
Legend Biotech (LEGN) United States $10.807B 0.00
Sarepta Therapeutics (SRPT) United States $10.482B 0.00
Repligen (RGEN) United States $9.228B 63.17
QIAGEN (QGEN) Netherlands $9.145B 19.28
Roivant Sciences (ROIV) United Kingdom $8.335B 0.00
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $6.961B 0.00
Exelixis (EXEL) United States $6.820B 42.00
Karuna Therapeutics (KRTX) United States $6.575B 0.00
Reata Pharmaceuticals (RETA) United States $6.566B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $5.888B 19.00
Apellis Pharmaceuticals (APLS) United States $5.687B 0.00
Ascendis Pharma (ASND) Denmark $5.606B 0.00
Halozyme Therapeutics (HALO) United States $5.246B 17.68
Intra-Cellular Therapies (ITCI) United States $5.215B 0.00
Alkermes (ALKS) Ireland $4.982B 249.25
Vaxcyte (PCVX) United States $4.712B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.002B 0.00
Ginkgo Bioworks Holdings (DNA) United States $3.820B 0.00
Insmed (INSM) United States $3.783B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.766B 0.00
Amicus Therapeutics (FOLD) United States $3.704B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.537B 0.00
Axsome Therapeutics (AXSM) United States $3.445B 0.00
Krystal Biotech (KRYS) United States $3.391B 0.00
Guardant Health (GH) United States $3.248B 0.00
Cytokinetics (CYTK) United States $3.161B 0.00
Blueprint Medicines (BPMC) United States $3.114B 0.00
Intellia Therapeutics (NTLA) United States $3.041B 0.00
Denali Therapeutics (DNLI) United States $3.036B 0.00
Akero Therapeutics (AKRO) United States $2.855B 0.00
Prothena (PRTA) Ireland $2.811B 0.00
Immunovant (IMVT) United States $2.807B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.796B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.602B 0.00
Morphic Holding (MORF) United States $2.515B 0.00
Fortrea Holdings (FTRE) United States $2.513B 0.00
Nuvalent (NUVL) United States $2.512B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.511B 0.00
Zai Lab (ZLAB) China $2.504B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.355B 0.00
Galapagos (GLPG) Belgium $2.354B 0.00
Certara (CERT) United States $2.274B 37.45
Harmony Biosciences Holdings (HRMY) United States $2.208B 12.27
Ventyx Biosciences (VTYX) United States $2.206B 0.00
Zealand Pharma (ZLDPF) Denmark $2.149B 0.00
Beam Therapeutics (BEAM) United States $1.944B 0.00
Mirati Therapeutics (MRTX) United States $1.896B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.850B 0.00
Dynavax Technologies (DVAX) United States $1.768B 19.07
Arcellx (ACLX) United States $1.750B 0.00
CureVac (CVAC) Germany $1.730B 0.00
Bavarian Nordic (BVNRY) Denmark $1.718B 10.35
IDEAYA Biosciences (IDYA) United States $1.685B 0.00
NeoGenomics (NEO) United States $1.629B 0.00
Vericel (VCEL) United States $1.604B 0.00
SpringWorks Therapeutics (SWTX) United States $1.596B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $1.565B 0.00
Arcus Biosciences (RCUS) United States $1.518B 0.00
AbCellera Biologics (ABCL) Canada $1.470B 0.00
Myriad Genetics (MYGN) United States $1.422B 0.00
Viking Therapeutics (VKTX) United States $1.380B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.358B 0.00
Structure Therapeutics (GPCR) United States $1.347B 0.00
Iovance Biotherapeutics (IOVA) United States $1.345B 0.00
Vir Biotechnology (VIR) United States $1.322B 0.00
Arvinas (ARVN) United States $1.312B 0.00
89BIO (ETNB) United States $1.261B 0.00
Celldex Therapeutics (CLDX) United States $1.258B 0.00
Merus (MRUS) Netherlands $1.245B 0.00
ANI Pharmaceuticals (ANIP) United States $1.239B 19.83
Biohaven (BHVN) United States $1.234B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.231B 33.09
Day One Biopharmaceuticals (DAWN) United States $1.223B 0.00
Revance Therapeutics (RVNC) United States $1.215B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.187B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.186B 0.00
Prime Medicine (PRME) United States $1.172B 0.00
Twist Bioscience (TWST) United States $1.167B 0.00
Apogee Therapeutics (APGE) United States $1.164B 0.00
Disc Medicine (IRON) United States $1.163B 0.00
Geron (GERN) United States $1.146B 0.00
MannKind (MNKD) United States $1.138B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.104B 0.00
Ligand Pharmaceuticals (LGND) United States $1.099B 24.35
Replimune (REPL) United States $1.052B 0.00
Keros Therapeutics (KROS) United States $1.043B 0.00
Kymera Therapeutics (KYMR) United States $1.039B 0.00
Protagonist Therapeutics (PTGX) United States $1.017B 0.00
ACELYRIN, INC (SLRN) United States $0.993B 0.00
Pliant Therapeutics (PLRX) United States $0.993B 0.00
Travere Therapeutics (TVTX) United States $0.989B 0.00
Immatics (IMTX) Germany $0.948B 0.00
Northwest Biotherapeutics (NWBO) United States $0.932B 0.00
Cogent Biosciences (COGT) United States $0.914B 0.00
MiMedx (MDXG) United States $0.911B 0.00
Inhibrx (INBX) United States $0.906B 0.00
Pharming Group (PHAR) Netherlands $0.906B 0.00
Cytek Biosciences (CTKB) United States $0.875B 0.00
Tango Therapeutics (TNGX) United States $0.867B 0.00
Sana Biotechnology (SANA) United States $0.865B 0.00
Belite Bio (BLTE) United States $0.844B 0.00
ADMA Biologics Inc (ADMA) United States $0.821B 0.00
ImmunityBio (IBRX) United States $0.817B 0.00
Pharming Group (PHGUF) Netherlands $0.802B 0.00
PureTech Health (PRTC) United States $0.796B 0.00
REGENXBIO (RGNX) United States $0.787B 0.00
Adaptive Biotechnologies (ADPT) United States $0.784B 0.00
POINT Biopharma Global (PNT) United States $0.764B 8.30
Viridian Therapeutics (VRDN) United States $0.745B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.742B 14.67
Vera Therapeutics (VERA) United States $0.733B 0.00
Novavax (NVAX) United States $0.725B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.723B 0.00
Kura Oncology (KURA) United States $0.715B 0.00
Ambrx Biopharma (AMAM) United States $0.703B 0.00
Cabaletta Bio (CABA) United States $0.691B 0.00
Genelux (GNLX) United States $0.685B 0.00
Rapt Therapeutics (RAPT) United States $0.656B 0.00
Allogene Therapeutics (ALLO) United States $0.655B 0.00
Editas Medicine (EDIT) United States $0.652B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.647B 0.00
Sinovac Biotech (SVA) China $0.644B 0.00
Tyra Biosciences (TYRA) United States $0.632B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.629B 0.00
Pharma Mar (PHMMF) Spain $0.621B 0.00
Avid Bioservices (CDMO) United States $0.613B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.593B 0.00
Anavex Life Sciences (AVXL) United States $0.583B 0.00
HilleVax (HLVX) United States $0.569B 0.00
Tarsus Pharmaceuticals (TARS) United States $0.554B 0.00
Alector (ALEC) United States $0.552B 0.00
Avidity Biosciences (RNA) United States $0.541B 0.00
Biomea Fusion (BMEA) United States $0.534B 0.00
Repare Therapeutics (RPTX) Canada $0.529B 0.00
WAVE Life Sciences (WVE) Singapore $0.528B 0.00
Olema Pharmaceuticals (OLMA) United States $0.523B 0.00
AnaptysBio (ANAB) United States $0.492B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.486B 0.00
23andMe Holding (ME) United States $0.482B 0.00
Caribou Biosciences (CRBU) United States $0.481B 0.00
Entrada Therapeutics (TRDA) United States $0.477B 0.00
Agenus (AGEN) United States $0.471B 0.00
Zymeworks (ZYME) United States $0.468B 2.46
Intercept Pharmaceuticals (ICPT) United States $0.462B 0.00
Oric Pharmaceuticals (ORIC) United States $0.458B 0.00
Oculis Holding AG (OCS) Switzerland $0.455B 0.00
Nurix Therapeutics (NRIX) United States $0.450B 0.00
Castle Biosciences (CSTL) United States $0.450B 0.00
ITeos Therapeutics (ITOS) United States $0.448B 0.00
Janux Therapeutics (JANX) United States $0.444B 0.00
Cullinan Oncology (CGEM) United States $0.438B 0.00
Mineralys Therapeutics (MLYS) United States $0.436B 0.00
Coherus BioSciences (CHRS) United States $0.436B 0.00
IGM Biosciences (IGMS) United States $0.423B 0.00
Liquidia Technologies (LQDA) United States $0.420B 0.00
Icosavax (ICVX) United States $0.417B 0.00
Nautilus Biotechnology (NAUT) United States $0.412B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.403B 0.00
Amarin (AMRN) Ireland $0.400B 0.00
Edgewise Therapeutics (EWTX) United States $0.392B 0.00
Scholar Rock Holding (SRRK) United States $0.389B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.385B 0.00
Urogen Pharma (URGN) United States $0.382B 0.00
Aerovate Therapeutics (AVTE) United States $0.372B 0.00
Aura Biosciences (AURA) United States $0.371B 0.00
Erasca (ERAS) United States $0.364B 0.00
UniQure (QURE) Netherlands $0.363B 0.00
Seres Therapeutics (MCRB) United States $0.355B 0.00
Voyager Therapeutics (VYGR) United States $0.353B 3.54
Bluebird Bio (BLUE) United States $0.343B 0.00
MaxCyte (MXCT) United States $0.338B 0.00
Precigen (PGEN) United States $0.337B 0.00
Apollomics (APLM) Taiwan $0.334B 0.00
Arbutus Biopharma (ABUS) United States $0.332B 0.00
MeiraGTx Holdings (MGTX) United States $0.329B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.328B 0.00
Terns Pharmaceuticals (TERN) United States $0.321B 0.00
Humacyte (HUMA) United States $0.314B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.300B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.300B 0.00
AN2 Therapeutics (ANTX) United States $0.298B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.298B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.295B 0.00
Nuvation Bio (NUVB) United States $0.289B 0.00
Scilex Holding (SCLX) United States $0.279B 0.00
DBV Technologies S.A (DBVT) France $0.275B 0.00
Ovid Therapeutics (OVID) United States $0.272B 0.00
Atea Pharmaceuticals (AVIR) United States $0.271B 0.00
Inozyme Pharma (INZY) United States $0.269B 0.00
Fulcrum Therapeutics (FULC) United States $0.266B 0.00
ScPharmaceuticals (SCPH) United States $0.261B 0.00
Anika Therapeutics (ANIK) United States $0.260B 0.00
Compass Therapeutics (CMPX) United States $0.256B 0.00
Sagimet Biosciences (SGMT) United States $0.253B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.252B 16.26
AC Immune (ACIU) Switzerland $0.252B 0.00
Third Harmonic Bio (THRD) United States $0.250B 0.00
Lifecore Biomedical (LFCR) United States $0.250B 0.00
Zura Bio (ZURA) United States $0.248B 0.00
Nuvectis Pharma (NVCT) United States $0.245B 0.00
Verastem (VSTM) United States $0.240B 0.00
Vigil Neuroscience (VIGL) United States $0.239B 0.00
Gracell Biotechnologies (GRCL) China $0.236B 0.00
Kamada (KMDA) Israel $0.236B 18.17
Fate Therapeutics (FATE) United States $0.232B 0.00
Immuneering (IMRX) United States $0.231B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.228B 0.00
Sutro Biopharma (STRO) United States $0.226B 0.00
Celcuity (CELC) United States $0.222B 0.00
Mesoblast (MESO) Australia $0.220B 0.00
Akoya Biosciences (AKYA) United States $0.218B 0.00
Innate Pharma S.A (IPHA) France $0.215B 0.00
Astria Therapeutics (ATXS) United States $0.213B 0.00
Stoke Therapeutics (STOK) United States $0.211B 0.00
Gossamer Bio (GOSS) United States $0.210B 0.00
CorMedix Inc (CRMD) United States $0.208B 0.00
TELA Bio (TELA) United States $0.204B 0.00
ALX Oncology Holdings (ALXO) United States $0.204B 0.00
Invivyd (IVVD) United States $0.201B 0.00
Inventiva S.A (IVA) France $0.197B 0.00
Emergent Biosolutions (EBS) United States $0.195B 0.00
Allakos (ALLK) United States $0.192B 0.00
Praxis Precision Medicines (PRAX) United States $0.190B 0.00
Tenaya Therapeutics (TNYA) United States $0.186B 0.00
XOMA (XOMA) United States $0.186B 0.00
Ikena Oncology (IKNA) United States $0.185B 0.00
Vaxxinity (VAXX) United States $0.185B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.184B 0.00
X4 Pharmaceuticals (XFOR) United States $0.179B 0.00
Rallybio (RLYB) United States $0.178B 0.00
GENFIT S.A (GNFT) France $0.177B 0.00
2seventy Bio (TSVT) United States $0.177B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.176B 0.00
Prima BioMed (IMMP) Australia $0.173B 0.00
Renovaro Biosciences (RENB) United States $0.172B 0.00
Poseida Therapeutics (PSTX) United States $0.167B 0.00
Selecta Biosciences (SELB) United States $0.166B 0.00
PDS Biotechnology (PDSB) United States $0.165B 0.00
Mersana Therapeutics (MRSN) United States $0.163B 0.00
LianBio (LIAN) United States $0.162B 0.00
Adverum Biotechnologies (ADVM) United States $0.161B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.160B 0.00
Atara Biotherapeutics (ATRA) United States $0.160B 0.00
Applied Therapeutics (APLT) United States $0.160B 0.00
InflaRx (IFRX) Germany $0.158B 0.00
Molecular Partners AG (MOLN) Switzerland $0.158B 0.00
Seer (SEER) United States $0.155B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.154B 0.00
Omega Therapeutics (OMGA) United States $0.153B 0.00
Oncolytics Biotech (ONCY) Canada $0.151B 0.00
Sangamo Therapeutics (SGMO) United States $0.150B 0.00
Vor Biopharma (VOR) $0.147B 0.00
Rani Therapeutics Holdings (RANI) United States $0.146B 0.00
Absci (ABSI) United States $0.146B 0.00
Graphite Bio (GRPH) United States $0.142B 0.00
Puma Biotechnology (PBYI) United States $0.142B 0.00
Annexon (ANNX) United States $0.141B 0.00
TScan Therapeutics (TCRX) United States $0.141B 0.00
XBiotech (XBIT) United States $0.139B 0.00
Design Therapeutics (DSGN) United States $0.139B 0.00
Ocean Biomedical (OCEA) United States $0.139B 0.00
Trevi Therapeutics (TRVI) United States $0.139B 0.00
Adocia (ADOCY) France $0.135B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.134B 0.00
PepGen (PEPG) United States $0.133B 0.00
Aadi Bioscience (AADI) United States $0.132B 0.00
INmune Bio (INMB) United States $0.131B 0.00
Gritstone Bio (GRTS) United States $0.128B 0.00
Seelos Therapeutics (SEEL) United States $0.128B 0.00
Decibel Therapeutics (DBTX) United States $0.126B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.126B 0.00
Theseus Pharmaceuticals (THRX) United States $0.125B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.124B 0.00
Codexis (CDXS) United States $0.122B 0.00
Greenwich LifeSciences (GLSI) United States $0.114B 0.00
Eton Pharmaceuticals (ETON) United States $0.114B 0.00
DiaMedica Therapeutics (DMAC) United States $0.114B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.111B 0.00
I-Mab (IMAB) China $0.111B 0.00
Kodiak Sciences (KOD) United States $0.110B 0.00
Opthea (OPT) Australia $0.110B 0.00
Graf Acquisition IV (GFOR) United States $0.109B 0.00
C4 Therapeutics (CCCC) United States $0.109B 0.00
Inovio Pharmaceuticals (INO) United States $0.108B 0.00
Gamida Cell (GMDA) United States $0.107B 0.00
ChromaDex (CDXC) United States $0.107B 0.00
Cue Biopharma (CUE) United States $0.106B 0.00
Bionano Genomics (BNGO) United States $0.106B 0.00
Cara Therapeutics (CARA) United States $0.105B 0.00
Ocugen (OCGN) United States $0.103B 0.00
MediciNova (MNOV) United States $0.103B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.102B 0.00
NGM Biopharmaceuticals (NGM) United States $0.102B 0.00
Spruce Biosciences (SPRB) United States $0.099B 0.00
Genenta Science S.p.A (GNTA) Italy $0.099B 0.00
Turnstone Biologics (TSBX) United States $0.098B 0.00
PhenomeX (CELL) United States $0.098B 0.00
Annovis Bio (ANVS) United States $0.097B 0.00
BioAtla (BCAB) United States $0.096B 0.00
Cidara Therapeutics (CDTX) United States $0.095B 0.00
Beyond Air (XAIR) United States $0.094B 0.00
Abeona Therapeutics (ABEO) United States $0.094B 0.00
BRIACELL THERAP (BCTX) Canada $0.093B 0.00
ATyr Pharma (LIFE) United States $0.092B 0.00
IO Biotech (IOBT) Denmark $0.092B 0.00
BioXcel Therapeutics (BTAI) United States $0.091B 0.00
Cellectis S.A (CLLS) France $0.091B 0.00
CytomX Therapeutics (CTMX) United States $0.090B 0.00
Evelo Biosciences (EVLO) United States $0.090B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.089B 0.00
Werewolf Therapeutics (HOWL) United States $0.089B 0.00
Compugen (CGEN) Israel $0.088B 0.00
Immunome (IMNM) United States $0.087B 0.00
Kezar Life Sciences (KZR) United States $0.087B 0.00
Jasper Therapeutics (JSPR) United States $0.086B 0.00
Data Knights Acquisition (DKDCA) United Kingdom $0.085B 0.00
Ocuphire Pharma (OCUP) United States $0.084B 4.77
Sorrento Therapeutics (SRNEQ) United States $0.082B 0.00
Syros Pharmaceuticals (SYRS) United States $0.081B 0.00
Nkarta (NKTX) United States $0.080B 0.00
Shattuck Labs (STTK) United States $0.079B 0.00
Genetron Holdings (GTH) China $0.078B 0.00
Athira Pharma (ATHA) United States $0.078B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.076B 0.00
Kronos Bio (KRON) United States $0.076B 0.00
HCW Biologics (HCWB) United States $0.074B 0.00
Adicet Bio (ACET) United States $0.073B 0.00
Cardiff Oncology (CRDF) United States $0.073B 0.00
Affimed (AFMD) Germany $0.072B 0.00
Kinnate Biopharma (KNTE) United States $0.071B 0.00
Enzo Biochem (ENZ) United States $0.071B 0.00
G1 Therapeutics (GTHX) United States $0.070B 0.00
AVROBIO (AVRO) United States $0.070B 0.00
Elicio Therapeutics (ELTX) United States $0.069B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.069B 0.00
Xilio Therapeutics (XLO) United States $0.067B 0.00
Vaccitech (VACC) United Kingdom $0.067B 0.00
Prenetics Global (PRE) Cayman Islands $0.067B 1.57
Spero Therapeutics (SPRO) United States $0.065B 0.00
Eyenovia (EYEN) United States $0.065B 0.00
Clene (CLNN) United States $0.063B 0.00
Immunic (IMUX) United States $0.062B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.061B 0.00
Adagene (ADAG) China $0.061B 0.00
Oncobiologics (OTLK) United States $0.059B 0.00
Solid Biosciences (SLDB) United States $0.058B 0.00
Instil Bio (TIL) United States $0.057B 0.00
Intensity Therapeutics (INTS) United States $0.055B 0.00
Dyadic (DYAI) United States $0.055B 0.00
Immix Biopharma (IMMX) United States $0.054B 0.00
Rezolute (RZLT) United States $0.053B 0.00
Curis (CRIS) United States $0.053B 0.00
VistaGen Therapeutics (VTGN) United States $0.052B 0.00
Clearside Biomedical (CLSD) United States $0.052B 0.00
Theratechnologies (THTX) Canada $0.052B 0.00
HOOKIPA Pharma (HOOK) United States $0.052B 0.00
Alpha Teknova (TKNO) United States $0.051B 0.00
Dianthus Therapeutics (DNTH) United States $0.050B 0.00
OKYO Pharma (OKYO) $0.050B 0.00
VTv Therapeutics (VTVT) United States $0.049B 0.00
Precision BioSciences (DTIL) United States $0.049B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.049B 0.00
Portage Biotech (PRTG) $0.047B 0.00
Celularity (CELU) United States $0.047B 0.00
Longeveron (LGVN) United States $0.047B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.046B 0.00
Quince Therapeutics (QNCX) United States $0.045B 0.00
MiNK Therapeutics (INKT) United States $0.045B 0.00
Fortress Biotech (FBIO) United States $0.044B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Galena Biopharma (SLS) United States $0.043B 0.00
Bolt Biotherapeutics (BOLT) United States $0.043B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.041B 0.00
Dare Bioscience (DARE) United States $0.041B 0.00
Coya Therapeutics (COYA) United States $0.041B 0.00
Science 37 Holdings (SNCE) United States $0.040B 0.00
Connect Biopharma Holdings (CNTB) United States $0.039B 0.00
Passage Bio (PASG) United States $0.039B 0.00
Cognition Therapeutics (CGTX) United States $0.039B 0.00
Miromatrix Medical (MIRO) United States $0.038B 0.00
Checkpoint Therapeutics (CKPT) United States $0.038B 0.00
Telesis Bio (TBIO) United States $0.038B 0.00
Mainz Biomed (MYNZ) Germany $0.037B 0.00
Leap Therapeutics (LPTX) United States $0.037B 0.00
NextCure (NXTC) United States $0.037B 0.00
UNITY Biotechnology (UBX) United States $0.037B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.035B 0.00
NuCana (NCNA) United Kingdom $0.035B 0.00
Candel Therapeutics (CADL) United States $0.035B 0.00
Aligos Therapeutics (ALGS) United States $0.034B 0.00
BeyondSpring (BYSI) United States $0.033B 0.00
IN8bio (INAB) United States $0.033B 0.00
Cyclo Therapeutics (CYTH) United States $0.033B 0.00
Neoleukin Therapeutics (NLTX) United States $0.033B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.032B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.031B 0.00
SAB Biotherapeutics (SABS) United States $0.031B 0.00
Rain Oncology (RAIN) United States $0.031B 0.00
Elevation Oncology (ELEV) United States $0.030B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.029B 0.00
Forte Biosciences (FBRX) United States $0.029B 0.00
Biora Therapeutics (BIOR) United States $0.029B 0.00
Evogene (EVGN) Israel $0.028B 0.00
Equillium (EQ) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
KALA BIO (KALA) United States $0.027B 0.00
GENPREX (GNPX) United States $0.027B 0.00
Elutia (ELUT) United States $0.027B 0.00
Liminal BioSciences (LMNL) Canada $0.026B 0.00
Pluri (PLUR) Israel $0.026B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.025B 0.00
Aptose Biosciences (APTO) Canada $0.024B 0.00
Lumos Pharma (LUMO) United States $0.024B 0.00
Senti Biosciences (SNTI) United States $0.024B 0.00
Kineta (KA) United States $0.023B 0.00
Alzamend Neuro (ALZN) United States $0.023B 0.00
YS Biopharma (YS) China $0.023B 1.10
Sensei Biotherapeutics (SNSE) United States $0.023B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.022B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.022B 0.00
Synlogic (SYBX) United States $0.022B 0.00
TradeUP Acquisition (UPTD) United States $0.021B 0.00
Catalyst Biosciences (CBIO) United States $0.021B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.021B 0.00
Virios Therapeutics (VIRI) United States $0.021B 0.00
Medicenna Therapeutics (MDNA) Canada $0.021B 0.00
Purple Biotech (PPBT) Israel $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.020B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
VBI Vaccines (VBIV) United States $0.020B 0.00
Mustang Bio (MBIO) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Acorda Therapeutics (ACOR) United States $0.020B 0.00
Edesa Biotech (EDSA) Canada $0.019B 0.00
Orgenesis (ORGS) United States $0.018B 0.00
Freeline Therapeutics Holdings (FRLN) United Kingdom $0.018B 0.00
Promis Neurosciences (PMN) Canada $0.018B 0.00
PHAXIAM Therapeutics S.A (PHXM) France $0.018B 0.00
AquaBounty Technologies (AQB) United States $0.018B 0.00
Vascular Biogenics (VBLT) Israel $0.018B 0.00
CalciMedica (CALC) United States $0.018B 0.00
Lisata Therapeutics (LSTA) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Galecto (GLTO) Denmark $0.016B 0.00
RenovoRx (RNXT) United States $0.016B 0.00
Aprea Therapeutics (APRE) United States $0.015B 0.00
Senesco Technologies (ELOX) United States $0.015B 0.00
Frequency Therapeutics (FREQ) United States $0.015B 0.00
ZIVO Bioscience (ZIVO) United States $0.015B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.014B 0.00
BioAffinity Technologies (BIAF) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Atreca (BCEL) United States $0.014B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.014B 0.00
Evaxion Biotech (EVAX) Denmark $0.013B 0.00
Organovo Holdings (ONVO) United States $0.013B 0.00
AEterna Zentaris (AEZS) Canada $0.013B 0.00
TFF Pharmaceuticals (TFFP) United States $0.012B 0.00
Landos Biopharma (LABP) United States $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.012B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.012B 0.00
Pasithea Therapeutics (KTTA) United States $0.012B 0.00
ARAVIVE, INC (ARAV) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cingulate (CING) United States $0.011B 0.00
Chemomab Therapeutics (CMMB) Israel $0.011B 0.00
Avalon GloboCare (ALBT) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
Imunon (IMNN) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Talis Biomedical (TLIS) United States $0.010B 0.00
GT Biopharma (GTBP) United States $0.010B 0.00
Sunshine Biopharma (SBFM) Canada $0.010B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.010B 0.00
Blue Water Biotech (BWV) United States $0.010B 0.00
Cadrenal Therapeutics (CVKD) United States $0.010B 0.00
Trevena (TRVN) United States $0.010B 0.00
Comera Life Sciences Holdings (CMRA) United States $0.010B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Galera Therapeutics (GRTX) United States $0.009B 0.00
Bionomics (BNOX) Australia $0.009B 0.00
Monopar Therapeutics (MNPR) United States $0.009B 0.00
BioCardia (BCDA) United States $0.008B 0.00
Cohbar (CWBR) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Atrinsic (PTIX) United States $0.008B 0.00
Applied Molecular Transport (AMTI) United States $0.008B 0.00
Biorestorative Therapies (BRTX) United States $0.008B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.007B 0.00
Lexaria Bioscience (LEXX) Canada $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
TRACON Pharmaceuticals (TCON) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Aileron Therapeutics (ALRN) United States $0.007B 0.00
CervoMed (CRVO) United States $0.007B 0.00
Athersys (ATHX) United States $0.007B 0.00
Kintara Therapeutics (KTRA) United States $0.007B 0.00
Exicure (XCUR) United States $0.007B 0.46
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Biophytis SA (BPTS) France $0.006B 0.00
Aytu BioPharma (AYTU) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
NexImmune (NEXI) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
Benitec Biopharma (BNTC) United States $0.005B 0.00
Femasys (FEMY) United States $0.005B 0.00
Bellerophon Therapeutics (BLPH) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
ABVC BioPharma (ABVC) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Aptevo Therapeutics (APVO) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Hillstream BioPharma (HILS) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.04
Panbela Therapeutics (PBLA) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.27
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
NeuBase Therapeutics (NBSE) United States $0.003B 0.00
First Wave BioPharma (FWBI) United States $0.003B 0.07
Invo BioScience (INVO) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
MorphoSys AG (MOR) Germany $0.000B 17.98
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
ARCA Biopharma (ABIO) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Axcella Health (AXLA) United States $0.000B 0.00
Biofrontera (BFRI) United States $0.000B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
GH Research (GHRS) Ireland $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00